BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Academy of Nutritional Medicine - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Academy of Nutritional Medicine
X-ORIGINAL-URL:https://aonm.org
X-WR-CALDESC:Events for Academy of Nutritional Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261013T190000
DTEND;TZID=Europe/London:20261013T200000
DTSTAMP:20260910T105626Z
CREATED:20260910T105355Z
LAST-MODIFIED:20260910T105626Z
UID:44787-1791918000-1791921600@aonm.org
SUMMARY:[WEBINAR]  Hormone Therapy\, Chemotherapy\, and Antibody Treatment in Breast Cancer – Effects on Tumour Cells in the Blood
DESCRIPTION:Hormone Therapy\, Chemotherapy\, and Antibody Treatment in Breast Cancer – Effects on Tumour Cells in the Blood\nHow do different breast cancer treatments affect circulating tumour cells (CTCs) in the bloodstream\, and what can changes in these cells tell us about treatment response? \nJoin this specialist online webinar on Tuesday 13 October 2026 for an exploration of how different systemic treatment approaches—including hormone therapy\, chemotherapy and antibody-based treatments—can influence the number\, viability and dynamics of living tumour cells circulating in the blood. \nWhile treatment response is routinely assessed using a range of clinical and imaging measures\, monitoring circulating tumour cells can provide additional information that may be relevant when considering treatment response\, potential resistance and persistent tumour cell populations. \nThe webinar will use concrete clinical questions and examples to demonstrate how maintrac® and stemtrac® can be used to assess changes in living tumour cells during treatment. The session will also highlight current breast cancer-specific findings from ongoing research. \nTopics will include: \n\nThe effects of hormone therapy\, chemotherapy and antibody-based treatments on circulating tumour cells\nChanges in the number and viability of living tumour cells in the bloodstream\nUnderstanding the dynamics of circulating tumour cells during treatment\nHow monitoring may contribute to the assessment of treatment response\nIdentifying patterns that may raise questions around treatment resistance or persistent tumour cell populations\nClinical examples demonstrating the use of maintrac® and stemtrac®\nCurrent research findings relating specifically to breast cancer\n\nThis webinar will be particularly relevant to oncologists\, healthcare professionals involved in breast cancer care\, laboratory specialists and practitioners interested in circulating tumour cell monitoring and personalised approaches to treatment assessment.
URL:https://aonm.org/event/maintrac-meeting-october26/
ATTACH;FMTTYPE=image/jpeg:https://aonm.org/wp-content/uploads/2026/09/maintrac-stemtrac-labor_logobalken_dunkelblau_03-scaled.jpg
END:VEVENT
END:VCALENDAR